Mr. Rob Hill reports

EMERALD HEALTH THERAPEUTICS ENGAGES ACORN MANAGEMENT PARTNERS FOR INVESTOR RELATIONS

Emerald Health Therapeutics Inc. has engaged Acorn Management Partners, an Atlanta-based investor relations firm, to provide investor relations and communications services to the company, subject to TSX Venture Exchange acceptance.

Acorn has been engaged for a one-year term expiring July 29, 2019, and will be entitled to receive a monthly fee of $8,500 (U.S.). The agreement will automatically renew on a quarterly basis during the term and may be terminated by the company upon 30-day notice prior to the end of each quarter.

Acorn currently has no direct or indirect interest in the securities of the company, or any right or intent to acquire such an interest.

The appointment of Acorn as an investor relations consultant of the company remains subject to regulatory acceptance of applicable filings with the TSX Venture Exchange.

About Emerald Health Therapeutics Inc.

Emerald Health Therapeutics is licensed in Canada to produce and sell dried cannabis and cannabis oil for medical purposes. Emerald owns 50 per cent of Pure Sunfarms, which is converting a licensed existing 1.1-million-square-foot greenhouse in Delta, B.C., and is now in commercial production. It owns Agro-Biotech, a Quebec-based licensed cannabis grower with a 75,000-square-foot indoor facility, and is planning to add a 500,000-square-foot greenhouse in Metro Vancouver.